Gilead Hepatitis Elimination Webinar Series: Harm Reduction, Pt. 1: Community Education Group (USA)

In the first part of this episode, we focus on harm reduction and the work conducted by the Community Education Group (CEG), a community-based organization focusing on HIV prevention, advocacy and research in the Appalachia region in the United States. The Appalachia region is experiencing a severe syndemic of viral hepatitis and HIV, but CEG’s harm reduction work is helping the people who need it most. In this webinar, we learn from A. Toni Young, Founder and Executive Director of CEG as she shares the work that they’ve been doing to support people in the region. For more information about the Community Education Group (CEG), visit: Website: www.communityeducationgroup.org/thepartnershipfund… Facebook: www.facebook.com/CEGInWV/ Twitter: twitter.com/CEGInWV Instagram: www.instagram.com/ceginwv/?hl=en For more information about Gilead, visit: Website: www.gilead.com/ Stories@Gilead: stories.gilead.com/ Twitter: twitter.com/gileadsciences LinkedIn: linkedin.com/company/gileadsc... Instagram: www.instagram.com/gileadsciences Facebook: www.facebook.com/gileadsciences About Gilead Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. This webinar episode was created and fully funded by Gilead Sciences, Inc. GILEAD, the GILEAD logo, and the & design are trademarks of Gilead Sciences, Inc. © 2023 Gilead Sciences, Inc. All rights reserved.